Europe Warts Therapeuctis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Common Warts, Genital Warts, Flat Warts, and Others); Treatment (Physical Destruction, Immunomodulation, and Chemical Destruction); End User (Hospitals, Homecare, Specialty Clinics, and Others)
Market Introduction
Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.
Thus, the new product developments are expected to create a significant demand for warts therapeutics in the coming years, which is further anticipated to drive the warts therapeutics market.
The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. It is critical to reach Sustainable Development Goals (SDGs) and recent European guidance testing for HIV, hepatitis B (HBV), hepatitis C (HCV), and STIs in the pandemic. The COVID-19 required rapid adaptation of health systems and public health measures, and has had considerable impact on testing for HIV, viral hepatitis and STIs in the European Region. As per the Eurosurveillance, the preliminary results showed that 95% of respondents from 34 countries reported testing less than half the expected number of people during the first months of the COVID-19 between March and May 2020. This continued between June and August 2020 to a lesser extent when measures were less strict in most countries. These findings are indicating decline in testing volumes. With reported cases of COVID-19 being on the rise and restrictions being re-imposed in many countries, guidance is paramount to minimize testing interruptions and ensure the long-term sustainability of existing HIV, hepatitis and STIs testing services. Apart from this, the pandemic also led to drastic reductions in non-urgent medical visits including dermatology visits. Thus, the COVID-19 have negatively affected the market growth.
Get more information on this report :
Market Overview and Dynamics
The Warts therapeutics market in Europe is expected to grow from US$ 538.1 million in 2021 to US$ 667.6 million by 2028; it is estimated to grow at a CAGR of 3.1% from 2021 to 2028. Technological advancements are shaping warts treatments to overcome the shortcomings of the existing treatment procedures. Swift System, a new technology developed by Saorsa, provides a method to treat the viral infection causing plantar warts. The FDA approved this technique in 2018 after the proven research in Europe. The research showed that in over 13,000 patients treated with Swift, treatment was 85% effective in eliminating warts with less than 1% recurrence rate. It involves precisely exposing the skin to low-level microwave energy to a predetermined depth via a surface-contact probe, creating an immunologic response and harnessing the body's immune system to respond to the infection. Such innovations are likely to bring new trends in the warts therapeutical market in the coming years.
Key Market Segments
In terms of type, the common warts segment accounted for the largest share of the Europe warts therapeutics market in 2020. In terms of treatment, the physical destruction segment accounted for the largest share of the Europe warts therapeutics market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the Europe warts therapeutics market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the warts therapeutics market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bausch Health Companies Inc., Euro Vital Pharma GmbH, Cipla Inc., Koninklijke Utermöhlen NV, Scholl's Wellness Company, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline plc., and AIM ImmunoTech Inc.
Reasons to buy report
- To understand the Europe Warts therapeutics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe Warts therapeutics market
- Efficiently plan M&A and partnership deals in Europe Warts therapeutics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe Warts therapeutics market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
EUROPE WARTS THERAPEUTICS MARKET SEGMENTATION
By Type
- Common Warts
- Genital Warts
- Flat Warts
- Others
By Treatment
- Physical Destruction
- Cryotherapy
- Surgical Removal
- Laser Treatment
- Immunomodulation
- Interferons
- Retinoids
- Zinc
- Chemical Destruction
- Bleomycin
- Cantharidin
- Salicylic Acid
- Others
By End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- Bausch Health Companies Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Scholl's Wellness Company
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- AIM ImmunoTech Inc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Warts Therapeutics Market – By Type
1.3.2 Warts Therapeutics Market – By Treatment
1.3.3 Warts Therapeutics Market – By End User
1.3.4 Europe Warts Therapeutics Market – By Country
2. Europe Warts Therapeutics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Warts Therapeutics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Warts Therapeutics Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Warts Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Human Papillomavirus Infections and Recurrence of Genital Warts
5.1.2 New Product Developments
5.2 Market Restraints
5.2.1 Poor Diagnostics Scenario in Low-Income Countries
5.3 Market Opportunities
5.3.1 Increasing Awareness Regarding STIs
5.4 Future Trends
5.4.1 Emergence of New Technologies
5.5 Impact Analysis
6. Warts Therapeutics Market – Europe Analysis
6.1 Europe Warts Therapeutics Market Revenue Forecasts and Analysis
7. Europe Warts Therapeutics Market Analysis and Forecasts To 2028 – By Type
7.1 Overview
7.2 Warts Therapeutics Market Revenue Share, by Type (2020 and 2028)
7.3 Common Warts
7.3.1 Overview
7.3.2 Common Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Genital Warts
7.4.1 Overview
7.4.2 Genital Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Flat Warts
7.5.1 Overview
7.5.2 Flat Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Warts Therapeutics Market Analysis and Forecasts To 2028 – By Treatment
8.1 Overview
8.2 Warts Therapeutics Market Revenue Share, by Treatment (2020 and 2028)
8.3 Physical Destruction
8.3.1 Overview
8.3.2 Physical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Cryotherapy
8.3.2.2 Cryotherapy: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Surgical Removal
8.3.2.4 Surgical Removal: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.5 Laser Treatment
8.3.2.6 Laser Treatment: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Immunomodulation
8.4.1 Overview
8.4.2 Immunomodulation: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Interferons
8.4.2.2 Interferons: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.3 Retinoids
8.4.2.4 Retinoids: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.4.2.5 Zinc
8.4.2.6 Zinc: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Chemical Destruction
8.5.1 Overview
8.5.2 Chemical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Bleomycin
8.5.2.2 Bleomycin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3 Cantharidin
8.5.3.1 Overview
8.5.3.2 Cantharidin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3.3 Salicylic Acid
8.5.3.4 Salicylic Acid: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
8.5.3.5 Others
8.5.3.6 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
9. Warts Therapeutics Market Analysis – By End user
9.1 Overview
9.2 Warts Therapeutics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Warts Hospitals Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Homecare
9.4.1 Overview
9.4.2 Homecare: Warts Homecare Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Specialty Clinics
9.5.1 Overview
9.5.2 Specialty Clinics: Warts Specialty Clinics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
10. Warts Therapeutics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 Europe: Warts Therapeutics Market
10.1.1 Overview
10.1.2 Europe: Wart Therapeutics Market, by Country, 2021 & 2028 (%)
10.1.2.1 UK: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 UK: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 UK Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 UK Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.1 UK Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.2 UK Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.3 UK Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 UK Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Germany: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Germany: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Germany Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.3 Germany Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.3.1 Germany Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.3.2 Germany Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.3.3 Germany Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (Canada Million)
10.1.2.2.4 Germany Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (Canada Million)
10.1.2.3 France: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 France: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 France Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 France Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.1 France Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.2 France Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.3 France Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 France Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Italy: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Italy: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2 Italy Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Italy Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3.1 Italy Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3.2 Italy Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3.3 Italy Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Italy Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.5 Spain: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.1 Spain: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.2 Spain Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3 Spain Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3.1 Spain Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3.2 Spain Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3.3 Spain Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.5.4 Spain Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.6 Rest of Europe: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.1 Rest of Europe: Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.2 Rest of Europe Wart Therapeutics Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3 Rest of Europe Wart Therapeutics Market, by Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3.1 Rest of Europe Wart Therapeutics Market, by Physical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3.2 Rest of Europe Wart Therapeutics Market, by Immunomodulation Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3.3 Rest of Europe Wart Therapeutics Market, by Chemical Destruction Treatment– Revenue and Forecast to 2028 (USD Million)
10.1.2.6.4 Rest of Europe Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Europe Warts Therapeutics Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 Bausch Health Companies Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Euro Vital Pharma GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cipla Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Koninklijke Utermöhlen NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Scholl's Wellness Company
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GlaxoSmithKline plc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AIM ImmunoTech, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. UK Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. UK Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 3. UK Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 4. UK Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 5. UK Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. UK Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Germany Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (Canada Million)
Table 8. Germany Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (Canada Million)
Table 9. Germany Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (Canada Million)
Table 10. Germany Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (Canada Million)
Table 11. Germany Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (Canada Million)
Table 12. Germany Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (Canada Million)
Table 13. France Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. France Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 15. France Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 16. France Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 17. France Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 18. France Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 19. Italy Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 20. Italy Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 21. Italy Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 22. Italy Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 23. Italy Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 24. Italy Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 25. Spain Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 26. Spain Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 27. Spain Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 28. Spain Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 29. Spain Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 30. Spain Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe Wart Therapeutics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe Wart Therapeutics Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe Wart Therapeutics Market, by Physical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Europe Wart Therapeutics Market, by Immunomodulation Treatment – Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Europe Wart Therapeutics Market, by Chemical Destruction Treatment – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Europe Wart Therapeutics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 37. Organic Developments Done by Companies
Table 38. Inorganic Developments Done by Companies
Table 39. Glossary of Terms, Warts Therapeutics Market
LIST OF FIGURES
Figure 1. Warts Therapeutics Market Segmentation
Figure 2. Europe Warts Therapeutics Market Overview
Figure 3. Common Warts Segment Held Largest Share Of Type In Warts Therapeutics Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Warts Therapeutics Market - Europe PEST Analysis
Figure 6. Warts Therapeutics Market Impact Analysis of Driver and Restraints
Figure 7. Europe Warts Therapeutics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Warts Therapeutics Market Revenue Share, by Type (2020 and 2028)
Figure 9. Common Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Genital Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Flat Warts: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Warts Therapeutics Market Revenue Share, by Treatment (2020 and 2028)
Figure 14. Physical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Cryotherapy: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Surgical Removal: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Laser Treatment: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Immunomodulation: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Interferons: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Retinoids: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Zinc: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Chemical Destruction: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Bleomycin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cantharidin: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Salicylic Acid: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Warts Therapeutics Market Revenue Share, by End User (2020 and 2028)
Figure 28. Hospitals: Warts Hospitals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Homecare: Warts Homecare Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Specialty Clinics: Warts Specialty Clinics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Warts Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe: Warts Therapeutics Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. Europe: Wart Therapeutics Market, by Country, 2021 & 2028 (%)
Figure 34. UK Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Germany Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. France Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Italy Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Spain Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Rest of Europe Warts Therapeutics Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in European Country Markets
Figure 41. Growth Strategies Done by the Companies in the Market, (%)
- Bausch Health Companies Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Scholl's Wellness Company
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- AIM ImmunoTech Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe warts therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe warts therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the warts therapeutics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution